StockNews.com Upgrades Colgate-Palmolive (NYSE:CL) to Buy

Colgate-Palmolive (NYSE:CL) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday.

Several other analysts have also issued reports on the company. Hsbc Global Res lowered Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. Bank of America upped their price objective on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Morgan Stanley lifted their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Finally, Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $105.00 to $101.00 in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Stock Up 1.1 %

CL traded up $0.98 during trading on Wednesday, reaching $91.75. 421,578 shares of the stock were exchanged, compared to its average volume of 4,359,405. The stock has a market cap of $74.96 billion, a P/E ratio of 26.29, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock’s 50 day moving average price is $101.49 and its two-hundred day moving average price is $98.39. Colgate-Palmolive has a twelve month low of $74.67 and a twelve month high of $109.30.

Insider Transactions at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Norden Group LLC bought a new stake in Colgate-Palmolive during the first quarter worth $532,000. Rehmann Capital Advisory Group purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at about $238,000. Advisory Services Network LLC lifted its position in shares of Colgate-Palmolive by 2.7% during the first quarter. Advisory Services Network LLC now owns 69,038 shares of the company’s stock valued at $6,217,000 after purchasing an additional 1,809 shares in the last quarter. Empirical Finance LLC boosted its holdings in Colgate-Palmolive by 3.4% during the first quarter. Empirical Finance LLC now owns 30,329 shares of the company’s stock worth $2,731,000 after purchasing an additional 996 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its position in Colgate-Palmolive by 30.1% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 24,251 shares of the company’s stock worth $2,184,000 after purchasing an additional 5,614 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.